Bio-Rad Laboratories, Inc. Launches Syphilis IgG Kit for Use on Its BioPlex 2200 System

HERCULES, CA--(MARKET WIRE)--Aug 27, 2007 -- Bio-Rad Laboratories, Inc. (AMEX:BIO - News) and (AMEX:BIO-B - News), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has launched a test for syphilis for use on its BioPlex® 2200 system, a revolutionary diagnostic platform that employs multiplexing technology to analyze multiple disease markers from a single patient sample.

MORE ON THIS TOPIC